Keywords
Last Name
Institution

Jeffrey S Wasser MD

TitleAssistant Professor
InstitutionUConn Health Center
DepartmentMedicine
AddressMC 1628
MC 1628
263 Farmington Avenue
Phone860-679-2257
Fax860-679-4451
vCardDownload vCard
    Other Positions
    TitleHematologist and Medical Oncologist
    InstitutionUConn Health Center
    DepartmentNeag Comprehensive Cancer Center


    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Altomare I, Cetin K, Wetten S, Wasser JS. Rate of bleeding-related episodes in adult patients with primary immune thrombocytopenia: a retrospective cohort study using a large administrative medical claims database in the US. Clin Epidemiol. 2016; 8:231-9. PMID: 27382333.
      View in: PubMed
    2. Ryan JM, Wasser JS, Adler AJ, Vella AT. Enhancing the safety of antibody-based immunomodulatory cancer therapy without compromising therapeutic benefit: Can we have our cake and eat it too? Expert Opin Biol Ther. 2016 May; 16(5):655-74. PMID: 26855028.
      View in: PubMed
    3. Shimanovsky A, Patel D, Wasser J. Refractory Immune Thrombocytopenic Purpura and Cytomegalovirus Infection: A Call for a Change in the Current Guidelines. Mediterr J Hematol Infect Dis. 2016; 8(1):e2016010. PMID: 26740871.
      View in: PubMed
    4. Mittal P, St Rose MC, Wang X, Ryan JM, Wasser JS, Vella AT, Adler AJ. Tumor-Unrelated CD4 T Cell Help Augments CD134 plus CD137 Dual Costimulation Tumor Therapy. J Immunol. 2015 Dec 15; 195(12):5816-26. PMID: 26561553; PMCID: PMC4670784 [Available on 12/15/16].
    5. Michel M, Wasser J, Godeau B, Aledort L, Cooper N, Tomiyama Y, Khellaf M, Wang X. Efficacy and safety of the thrombopoietin receptor agonist romiplostim in patients aged =65 years with immune thrombocytopenia. Ann Hematol. 2015 Dec; 94(12):1973-80. PMID: 26341755.
      View in: PubMed
    6. Cines DB, Gernsheimer T, Wasser J, Godeau B, Provan D, Lyons R, Altomare I, Wang X, Lopez A. Integrated analysis of long-term safety in patients with chronic immune thrombocytopaenia (ITP) treated with the thrombopoietin (TPO) receptor agonist romiplostim. Int J Hematol. 2015 Sep; 102(3):259-70. PMID: 26201709.
      View in: PubMed
    7. Mar N, Vredenburgh JJ, Wasser JS. Targeting HER2 in the treatment of non-small cell lung cancer. Lung Cancer. 2015 Mar; 87(3):220-5. PMID: 25601485.
      View in: PubMed
    8. Bidros M, Wasser JS. Re: Hematophagocytic lymphohistiocytosis associated with dermatomyositis: a case report. Conn Med. 2014 Jan; 78(1):61-2. PMID: 24600789.
      View in: PubMed
    9. Kuter DJ, Bussel JB, Newland A, Baker RI, Lyons RM, Wasser J, Viallard JF, Macik G, Rummel M, Nie K, Jun S. Long-term treatment with romiplostim in patients with chronic immune thrombocytopenia: safety and efficacy. Br J Haematol. 2013 May; 161(3):411-23. PMID: 23432528.
      View in: PubMed
    10. Altomare I, Wasser J, Pullarkat V. Bleeding and mortality outcomes in ITP clinical trials: a review of thrombopoietin mimetics data. Am J Hematol. 2012 Oct; 87(10):984-7. PMID: 22729832.
      View in: PubMed
    11. Pullarkat VA, Gernsheimer TB, Wasser JS, Newland A, Guthrie TH, de Wolf JT, Stewart R, Berger D. Quantifying the reduction in immunoglobulin use over time in patients with chronic immune thrombocytopenic purpura receiving romiplostim (AMG 531). Am J Hematol. 2009 Aug; 84(8):538-40. PMID: 19569197.
      View in: PubMed
    12. Kuter DJ, Bussel JB, Lyons RM, Pullarkat V, Gernsheimer TB, Senecal FM, Aledort LM, George JN, Kessler CM, Sanz MA, Liebman HA, Slovick FT, de Wolf JT, Bourgeois E, Guthrie TH, Newland A, Wasser JS, Hamburg SI, Grande C, Lefrère F, Lichtin AE, Tarantino MD, Terebelo HR, Viallard JF, Cuevas FJ, Go RS, Henry DH, Redner RL, Rice L, Schipperus MR, Guo DM, Nichol JL. Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial. Lancet. 2008 Feb 2; 371(9610):395-403. PMID: 18242413.
      View in: PubMed
    13. Bussel JB, Kuter DJ, George JN, McMillan R, Aledort LM, Conklin GT, Lichtin AE, Lyons RM, Nieva J, Wasser JS, Wiznitzer I, Kelly R, Chen CF, Nichol JL. AMG 531, a thrombopoiesis-stimulating protein, for chronic ITP. N Engl J Med. 2006 Oct 19; 355(16):1672-81. PMID: 17050891.
      View in: PubMed
    14. Hudis CA, Vogel CL, Gralow JR, Williams D. Weekly epoetin alfa during adjuvant chemotherapy for breast cancer: effect on hemoglobin levels and quality of life. Clin Breast Cancer. 2005 Jun; 6(2):132-42. PMID: 16001991.
      View in: PubMed
    15. Aledort LM, Hayward CP, Chen MG, Nichol JL, Bussel J. Prospective screening of 205 patients with ITP, including diagnosis, serological markers, and the relationship between platelet counts, endogenous thrombopoietin, and circulating antithrombopoietin antibodies. Am J Hematol. 2004 Jul; 76(3):205-13. PMID: 15224353.
      View in: PubMed
    16. George JN, Woolf SH, Raskob GE, Wasser JS, Aledort LM, Ballem PJ, Blanchette VS, Bussel JB, Cines DB, Kelton JG, Lichtin AE, McMillan R, Okerbloom JA, Regan DH, Warrier I. Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood. 1996 Jul 1; 88(1):3-40. PMID: 8704187.
      View in: PubMed
    17. Coleman M, Saletan S, Wolf D, Nisce L, Wasser J, McIntyre OR, Tulloh M. Whole bone marrow irradiation for the treatment of multiple myeloma. Cancer. 1982 Apr 1; 49(7):1328-33. PMID: 7037161.
      View in: PubMed
    Wasser's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _